These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation. Shammas C; Byrou S; Phelan MM; Toumba M; Stylianou C; Skordis N; Neocleous V; Phylactou LA Hormones (Athens); 2016 Apr; 15(2):235-242. PubMed ID: 27376426 [TBL] [Abstract][Full Text] [Related]
4. Non-classical 11β-hydroxylase deficiency caused by a novel heterozygous mutation: a case report and review of the literature. Tang S; Xu W; Xuan M; Liu Q; Li Y; Kong D; Yang H; Liu Y; Xue Y Endocrine; 2024 Jun; 84(3):1193-1205. PubMed ID: 38411873 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic, metabolic, and molecular genetic characterization of six patients with congenital adrenal hyperplasia caused by novel mutations in the CYP11B1 gene. Nguyen HH; Eiden-Plach A; Hannemann F; Malunowicz EM; Hartmann MF; Wudy SA; Bernhardt R J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):126-34. PubMed ID: 26476331 [TBL] [Abstract][Full Text] [Related]
6. Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies. Peter M; Dubuis JM; Sippell WG Horm Res; 1999; 51(5):211-22. PubMed ID: 10559665 [TBL] [Abstract][Full Text] [Related]
7. Clinical and Hormonal Profiles Correlate With Molecular Characteristics in Patients With 11β-Hydroxylase Deficiency. Yildiz M; Isik E; Abali ZY; Keskin M; Ozbek MN; Bas F; Ucakturk SA; Buyukinan M; Onal H; Kara C; Storbeck KH; Darendeliler F; Cayir A; Unal E; Anik A; Demirbilek H; Cetin T; Dursun F; Catli G; Turan S; Falhammar H; Baris T; Yaman A; Haklar G; Bereket A; Guran T J Clin Endocrinol Metab; 2021 Aug; 106(9):e3714-e3724. PubMed ID: 33830237 [TBL] [Abstract][Full Text] [Related]
8. The molecular basis and genotype-phenotype correlations of congenital adrenal hyperplasia (CAH) in Anatolian population. Dundar A; Bayramov R; Onal MG; Akkus M; Dogan ME; Kenanoglu S; Cerrah Gunes M; Kazimli U; Ozbek MN; Ercan O; Yildirim R; Celmeli G; Parlak M; Dundar I; Hatipoglu N; Unluhizarci K; Akalin H; Ozkul Y; Saatci C; Dundar M Mol Biol Rep; 2019 Aug; 46(4):3677-3690. PubMed ID: 31006099 [TBL] [Abstract][Full Text] [Related]
9. Congenital adrenal hyperplasia due to 11-hydroxylase deficiency-Compound heterozygous mutations of a prevalent and two novel CYP11B1 mutations. Gu C; Tan H; Yang J; Lu Y; Ma Y Gene; 2017 Aug; 626():89-94. PubMed ID: 28514642 [TBL] [Abstract][Full Text] [Related]
10. Compound heterozygosity of a novel Q73X mutation and a known R141X mutation in CYP11B1 resulting in 11β-hydroxylase deficiency in a Chinese boy with congenital adrenal hyperplasia. Wei C; Zhang Z; Sang M; Dai H; Yang T; Sun M J Steroid Biochem Mol Biol; 2021 Jul; 211():105882. PubMed ID: 33785438 [TBL] [Abstract][Full Text] [Related]
11. A Novel Homozygous Pathogenic Variant in CYP11B1 in a Female Iranian Patient with 11B Hydroxylase Deficiency. Hoseinzadeh M; Molavi N; Norouzi M; Aghaei S; Zeinalian M; Hashemipour M; Tabatabaiefar MA Lab Med; 2023 Jul; 54(4):439-446. PubMed ID: 36493354 [TBL] [Abstract][Full Text] [Related]
12. Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation, p.G314R, in one CYP11B1 allele, and a chimeric CYP11B2/CYP11B1 in the other allele. Kuribayashi I; Nomoto S; Massa G; Oostdijk W; Wit JM; Wolffenbuttel BH; Shizuta Y; Honke K Horm Res; 2005; 63(6):284-93. PubMed ID: 16024935 [TBL] [Abstract][Full Text] [Related]
13. A Greek girl with 11β-hydroxylase deficiency due to compound heterozygosity for two novel mutations in CYP11B1 gene. Marakaki C; Papadopoulou A; Karapanou O; Papadimitriou DT; Kleanthous K; Papadimitriou A Endocrinol Diabetes Metab Case Rep; 2015; 2015():150074. PubMed ID: 26525354 [TBL] [Abstract][Full Text] [Related]
15. Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient. Ozbas B; Demir M; Dursun H; Sahin I; Hacioglu A; Karaca Z; Dundar M; Unluhizarci K Endocr Metab Immune Disord Drug Targets; 2023; 23(5):721-726. PubMed ID: 36214299 [TBL] [Abstract][Full Text] [Related]
16. Two novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11β hydroxylase deficiency in a Tunisian family. Ben Charfeddine I; Riepe FG; Kahloul N; Kulle AE; Adala L; Mamaï O; Amara A; Mili A; Amri F; Saad A; Holterhus PM; Gribaa M Gen Comp Endocrinol; 2012 Feb; 175(3):514-8. PubMed ID: 22210247 [TBL] [Abstract][Full Text] [Related]
17. Steroid 11-beta hydroxylase deficiency caused by compound heterozygosity for a novel mutation in intron 7 (IVS 7 DS+4A to G) in one CYP11B1 allele and R448H in exon 8 in the other. Dumic K; Wilson R; Thanasawat P; Grubic Z; Kusec V; Stingl K; New MI Eur J Pediatr; 2010 Jul; 169(7):891-4. PubMed ID: 20024693 [TBL] [Abstract][Full Text] [Related]
19. The combination of a novel 2 bp deletion mutation and p.D63H in CYP11B1 cause congenital adrenal hyperplasia due to steroid 11β-hydroxylase deficiency. Long Y; Han S; Zhang X; Zhang X; Chen T; Gao Y; Tian H Endocr J; 2016; 63(3):301-10. PubMed ID: 26806323 [TBL] [Abstract][Full Text] [Related]
20. Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis. Concolino P Mol Diagn Ther; 2024 Mar; 28(2):215-224. PubMed ID: 38324138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]